Effects of age on the optimal effect-site concentration of remifentanil for preventing cough during anesthetic emergence in male patients undergoing laparoscopic cholecystectomy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0002353

Enrollment

Registered

2017-06-13

Start date

2016-06-27

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : Young Age Group: 20-50 years old, Old Age Group:65-75 years old

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male patients (20-50 yrs or 65-75yrs) with American Society Anesthesiologist (ASA) physical status I or II undergoing laparoscopic cholecystectomy will be enrolled in this study.

Exclusion criteria

Exclusion criteria: Patients with predicted difficult airway, body mass index > 30 kg/m2, history of upper respiratory infection or respiratory disease, current smokers, uncontrolled hypertension or diabetes, moderate to severe coronary artery disease wilil be excluded from the study.

Design outcomes

Primary

Measure	Time frame
presence or absence of cough after extubation within 5 min	—

Secondary

Measure	Time frame
presence or absence of cough after extubation, changes of blood pressure, HR within 5 min of extubation	—

Countries

Korea, Republic of

Contacts

Public ContactSook Young Lee

Ajou University

anesy83@naver.com+82-31-219-4658

Outcome results